SCHEMBL7063369

SCHEMBL7063369

COC1CCC(CSC(C)=O)(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 18/20 0.65
CYP2D6 P10635 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063055 1.00 MMP1 (0.65) MMP1CYP2D6MAPT
SCHEMBL7063052 1.00 MMP1 (0.65) MMP1CYP2D6MAPT
SCHEMBL7981268 0.94 MMP1 (0.66) MMP1
SCHEMBL7981266 0.94 MMP1 (0.66) MMP1
SCHEMBL7981446 0.92 MMP1 (0.60) MMP1
SCHEMBL7981449 0.92 MMP1 (0.60) MMP1
SCHEMBL7985466 0.92 MMP1 (0.67) MMP1
SCHEMBL7971663 0.91 MMP1 (0.77) MMP1
SCHEMBL7971664 0.91 MMP1 (0.77) MMP1
SCHEMBL7990008 0.89 MMP1 (0.64) MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966439-B1 CERTAIN CYCLIC THIO SUBSTITUTED ACYLAMINOACID AMIDE DERIVATIVES NOVARTIS AG (CH) 2003-06-04 EP disclosed
US-6201133-B1 FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS, TREATING TNF ALPHA AND MATRIX METALLOPROTEINASE DEPENDENT DISEASES OR CONDITIONS, CANCER NOVARTIS AG (CH) 2001-03-13 US disclosed
US-6034136-A METALLOPROTEINASE INHIBITOR NOVARTIS AG (CH) 2000-03-07 US disclosed
EP-0966439-A1 CERTAIN CYCLIC THIO SUBSTITUTED ACYLAMINOACID AMIDE DERIVATIVES Novartis AG (CH) 1999-12-29 EP disclosed
WO-1998042662-A1 CERTAIN CYCLIC THIO SUBSTITUTED ACYLAMINOACID AMIDE DERIVATIVES NOVARTIS AG (CH) 1998-10-01 WO disclosed